Lawyers Give Their Tips to Spot Clinical Lab Fraud
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A lawyer advises medical laboratories on how to improve their avenues for reporting unethical behavior
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons
How the 2024 proposal will fare on Capitol Hill in 2025 remains to be seen, though